Literature DB >> 33977099

SEC62 and SEC63 Expression in Hepatocellular Carcinoma and Tumor-Surrounding Liver Tissue.

Markus Casper1, Maximilian Linxweiler2, Johannes Linxweiler3, Richard Zimmermann2, Matthias Glanemann3, Frank Lammert1, Susanne N Weber1.   

Abstract

INTRODUCTION: The endoplasmic reticulum transmembrane proteins Sec61, Sec62, and Sec63 are responsible for the intracellular trafficking of precursor proteins and affect intracellular signaling. SEC62 overexpression has been linked to various human cancers. Our aim was to investigate SEC62 and SEC63 expression in hepatocellular carcinoma (HCC) and surrounding liver tissue. PATIENTS AND METHODS: Primary liver tissue was collected from 11 consecutive patients (70 ± 9 years; 10 men) who underwent HCC resection. In the HCC and the tumor-surrounding liver tissue we investigated SEC62 und SEC63 mRNA expression using quantitative real-time PCR. For Sec62, immunohistochemistry was performed.
RESULTS: SEC62and SEC63 total mRNA contents were significantly (p = 0.001) higher in HCCs (CT 22.5 ± 0.4 and 22.6 ± 0.3) when compared to the surrounding tissue (CT 24.6 ± 0.6 and 25.1 ± 0.9). Using the comparative CTmethod, SEC62 and SEC63 expression in HCC was increased 5- and 8.1-fold, respectively, in comparison to surrounding tissue. For Sec62 immunohistochemistry, the mean immunoreactive scores (IRS) were 7.9 ± 2.9 for HCC and 4.8 ± 1.2 for non-tumorous liver (p = 0.027). The mean IRS in HCC were 5.7 ± 3.5 and 8.9 ± 2.3 for patients without (n = 3) and with tumor recurrence (n = 8), respectively.
CONCLUSIONS: Overexpression of SEC62 and SEC63 is a common feature of HCC. The role of Sec62 as a prognostic marker for tumor recurrence after surgery and its potential role in treatment stratification must be addressed in future studies.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Chronic liver disease; Endoplasmic reticulum; Gene expression; Hepatocarcinogenesis; Immunohistochemistry; Intracellular signaling; Liver cancer; Liver tumor

Year:  2021        PMID: 33977099      PMCID: PMC8077548          DOI: 10.1159/000513293

Source DB:  PubMed          Journal:  Visc Med        ISSN: 2297-4725


  29 in total

1.  Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma.

Authors:  Y J Chen; S H Yeh; J T Chen; C C Wu; M T Hsu; S F Tsai; P J Chen; C H Lin
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

2.  Identification of 3q oncogene SEC62 as a marker for distant metastasis and poor clinical outcome in invasive ductal breast cancer.

Authors:  Ferenc Zoltan Takacs; Julia Caroline Radosa; Maximilian Linxweiler; Mariz Kasoha; Rainer M Bohle; Florian Bochen; Clara Unger; Erich-Franz Solomayer; Bernard Schick; Ingolf Juhasz-Böss
Journal:  Arch Gynecol Obstet       Date:  2019-02-12       Impact factor: 2.344

3.  Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery.

Authors:  Fiorenza Fumagalli; Julia Noack; Timothy J Bergmann; Eduardo Cebollero; Giorgia Brambilla Pisoni; Elisa Fasana; Ilaria Fregno; Carmela Galli; Marisa Loi; Tatiana Soldà; Rocco D'Antuono; Andrea Raimondi; Martin Jung; Armin Melnyk; Stefan Schorr; Anne Schreiber; Luca Simonelli; Luca Varani; Caroline Wilson-Zbinden; Oliver Zerbe; Kay Hofmann; Matthias Peter; Manfredo Quadroni; Richard Zimmermann; Maurizio Molinari
Journal:  Nat Cell Biol       Date:  2016-10-17       Impact factor: 28.824

4.  HNPCC-associated small bowel cancer: clinical and molecular characteristics.

Authors:  Karsten Schulmann; Frank E Brasch; Erdmute Kunstmann; Christoph Engel; Constanze Pagenstecher; Holger Vogelsang; Stefan Krüger; Tilman Vogel; Hanns-Peter Knaebel; Josef Rüschoff; Stephan A Hahn; Magnus V Knebel-Doeberitz; Gabriela Moeslein; Stephen J Meltzer; Hans K Schackert; Christiane Tympner; Elisabeth Mangold; Wolff Schmiegel
Journal:  Gastroenterology       Date:  2005-03       Impact factor: 22.682

5.  Trifluoperazine Activates FOXO1-Related Signals to Inhibit Tumor Growth in Hepatocellular Carcinoma.

Authors:  Jingwen Jiang; Zhongxi Huang; Xuewu Chen; Rongcheng Luo; Hongbin Cai; Hairu Wang; Hui Zhang; Tao Sun; Yunfang Zhang
Journal:  DNA Cell Biol       Date:  2017-09-06       Impact factor: 3.311

6.  Global trends and predictions in hepatocellular carcinoma mortality.

Authors:  Paola Bertuccio; Federica Turati; Greta Carioli; Teresa Rodriguez; Carlo La Vecchia; Matteo Malvezzi; Eva Negri
Journal:  J Hepatol       Date:  2017-03-21       Impact factor: 25.083

7.  Sec62 protein level is crucial for the ER stress tolerance of prostate cancer.

Authors:  Markus Greiner; Birgit Kreutzer; Sven Lang; Volker Jung; Adolfo Cavalié; Gerhard Unteregger; Richard Zimmermann; Bernd Wullich
Journal:  Prostate       Date:  2011-01-12       Impact factor: 4.104

8.  Instabilotyping reveals unique mutational spectra in microsatellite-unstable gastric cancers.

Authors:  Yuriko Mori; Fumiaki Sato; Florin M Selaru; Andreea Olaru; Kellie Perry; Martha C Kimos; Gen Tamura; Nagahide Matsubara; Suna Wang; Yan Xu; Jing Yin; Tong-Tong Zou; Barbara Leggett; Joanne Young; Toshihiro Nukiwa; O Colin Stine; John M Abraham; David Shibata; Stephen J Meltzer
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

9.  Gene expression-based chemical genomics identifies potential therapeutic drugs in hepatocellular carcinoma.

Authors:  Ming-Huang Chen; Wu-Lung R Yang; Kuan-Ting Lin; Chia-Hung Liu; Yu-Wen Liu; Kai-Wen Huang; Peter Mu-Hsin Chang; Jin-Mei Lai; Chun-Nan Hsu; Kun-Mao Chao; Cheng-Yan Kao; Chi-Ying F Huang
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

10.  Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions.

Authors:  Maximilian Linxweiler; Florian Bochen; Bernhard Schick; Silke Wemmert; Basel Al Kadah; Markus Greiner; Andrea Hasenfus; Rainer-Maria Bohle; Ingolf Juhasz-Böss; Erich-Franz Solomayer; Zoltan Ferenc Takacs
Journal:  BMC Cancer       Date:  2016-08-23       Impact factor: 4.430

View more
  4 in total

Review 1.  Complexity and Specificity of Sec61-Channelopathies: Human Diseases Affecting Gating of the Sec61 Complex.

Authors:  Mark Sicking; Sven Lang; Florian Bochen; Andreas Roos; Joost P H Drenth; Muhammad Zakaria; Richard Zimmermann; Maximilian Linxweiler
Journal:  Cells       Date:  2021-04-27       Impact factor: 6.600

Review 2.  Emerging View on the Molecular Functions of Sec62 and Sec63 in Protein Translocation.

Authors:  Sung-Jun Jung; Hyun Kim
Journal:  Int J Mol Sci       Date:  2021-11-25       Impact factor: 5.923

3.  Antagonizing Sec62 function in intracellular Ca2+ homeostasis represents a novel therapeutic strategy for head and neck cancer.

Authors:  Sandrina Körner; Tillman Pick; Florian Bochen; Silke Wemmert; Christina Körbel; Michael D Menger; Adolfo Cavalié; Jan-Philipp Kühn; Bernhard Schick; Maximilian Linxweiler
Journal:  Front Physiol       Date:  2022-08-15       Impact factor: 4.755

Review 4.  The endoplasmic reticulum membrane protein Sec62 as potential therapeutic target in SEC62 overexpressing tumors.

Authors:  Julia S M Zimmermann; Johannes Linxweiler; Julia C Radosa; Maximilian Linxweiler; Richard Zimmermann
Journal:  Front Physiol       Date:  2022-10-03       Impact factor: 4.755

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.